TABLE 1 Europe Non Hodgkin Lymphoma Therapeutics Market, 2019 - 2022, USD Million
TABLE 2 Europe Non Hodgkin Lymphoma Therapeutics Market, 2023 - 2030, USD Million
TABLE 3 Europe Non Hodgkin Lymphoma Therapeutics Market by Cell Type, 2019 - 2022, USD Million
TABLE 4 Europe Non Hodgkin Lymphoma Therapeutics Market by Cell Type, 2023 - 2030, USD Million
TABLE 5 Europe B-Cell Lymphoma Market by Country, 2019 - 2022, USD Million
TABLE 6 Europe B-Cell Lymphoma Market by Country, 2023 - 2030, USD Million
TABLE 7 Europe T-Cell Lymphoma Market by Country, 2019 - 2022, USD Million
TABLE 8 Europe T-Cell Lymphoma Market by Country, 2023 - 2030, USD Million
TABLE 9 Europe Non Hodgkin Lymphoma Therapeutics Market by Therapy Type, 2019 - 2022, USD Million
TABLE 10 Europe Non Hodgkin Lymphoma Therapeutics Market by Therapy Type, 2023 - 2030, USD Million
TABLE 11 Europe Radiation Therapy Market by Country, 2019 - 2022, USD Million
TABLE 12 Europe Radiation Therapy Market by Country, 2023 - 2030, USD Million
TABLE 13 Europe Chemotherapy Market by Country, 2019 - 2022, USD Million
TABLE 14 Europe Chemotherapy Market by Country, 2023 - 2030, USD Million
TABLE 15 Europe Targeted Therapy Market by Country, 2019 - 2022, USD Million
TABLE 16 Europe Targeted Therapy Market by Country, 2023 - 2030, USD Million
TABLE 17 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 18 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 19 Europe Non Hodgkin Lymphoma Therapeutics Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Non Hodgkin Lymphoma Therapeutics Market by Country, 2023 - 2030, USD Million
TABLE 21 Germany Non Hodgkin Lymphoma Therapeutics Market, 2019 - 2022, USD Million
TABLE 22 Germany Non Hodgkin Lymphoma Therapeutics Market, 2023 - 2030, USD Million
TABLE 23 Germany Non Hodgkin Lymphoma Therapeutics Market by Cell Type, 2019 - 2022, USD Million
TABLE 24 Germany Non Hodgkin Lymphoma Therapeutics Market by Cell Type, 2023 - 2030, USD Million
TABLE 25 Germany Non Hodgkin Lymphoma Therapeutics Market by Therapy Type, 2019 - 2022, USD Million
TABLE 26 Germany Non Hodgkin Lymphoma Therapeutics Market by Therapy Type, 2023 - 2030, USD Million
TABLE 27 UK Non Hodgkin Lymphoma Therapeutics Market, 2019 - 2022, USD Million
TABLE 28 UK Non Hodgkin Lymphoma Therapeutics Market, 2023 - 2030, USD Million
TABLE 29 UK Non Hodgkin Lymphoma Therapeutics Market by Cell Type, 2019 - 2022, USD Million
TABLE 30 UK Non Hodgkin Lymphoma Therapeutics Market by Cell Type, 2023 - 2030, USD Million
TABLE 31 UK Non Hodgkin Lymphoma Therapeutics Market by Therapy Type, 2019 - 2022, USD Million
TABLE 32 UK Non Hodgkin Lymphoma Therapeutics Market by Therapy Type, 2023 - 2030, USD Million
TABLE 33 France Non Hodgkin Lymphoma Therapeutics Market, 2019 - 2022, USD Million
TABLE 34 France Non Hodgkin Lymphoma Therapeutics Market, 2023 - 2030, USD Million
TABLE 35 France Non Hodgkin Lymphoma Therapeutics Market by Cell Type, 2019 - 2022, USD Million
TABLE 36 France Non Hodgkin Lymphoma Therapeutics Market by Cell Type, 2023 - 2030, USD Million
TABLE 37 France Non Hodgkin Lymphoma Therapeutics Market by Therapy Type, 2019 - 2022, USD Million
TABLE 38 France Non Hodgkin Lymphoma Therapeutics Market by Therapy Type, 2023 - 2030, USD Million
TABLE 39 Russia Non Hodgkin Lymphoma Therapeutics Market, 2019 - 2022, USD Million
TABLE 40 Russia Non Hodgkin Lymphoma Therapeutics Market, 2023 - 2030, USD Million
TABLE 41 Russia Non Hodgkin Lymphoma Therapeutics Market by Cell Type, 2019 - 2022, USD Million
TABLE 42 Russia Non Hodgkin Lymphoma Therapeutics Market by Cell Type, 2023 - 2030, USD Million
TABLE 43 Russia Non Hodgkin Lymphoma Therapeutics Market by Therapy Type, 2019 - 2022, USD Million
TABLE 44 Russia Non Hodgkin Lymphoma Therapeutics Market by Therapy Type, 2023 - 2030, USD Million
TABLE 45 Spain Non Hodgkin Lymphoma Therapeutics Market, 2019 - 2022, USD Million
TABLE 46 Spain Non Hodgkin Lymphoma Therapeutics Market, 2023 - 2030, USD Million
TABLE 47 Spain Non Hodgkin Lymphoma Therapeutics Market by Cell Type, 2019 - 2022, USD Million
TABLE 48 Spain Non Hodgkin Lymphoma Therapeutics Market by Cell Type, 2023 - 2030, USD Million
TABLE 49 Spain Non Hodgkin Lymphoma Therapeutics Market by Therapy Type, 2019 - 2022, USD Million
TABLE 50 Spain Non Hodgkin Lymphoma Therapeutics Market by Therapy Type, 2023 - 2030, USD Million
TABLE 51 Italy Non Hodgkin Lymphoma Therapeutics Market, 2019 - 2022, USD Million
TABLE 52 Italy Non Hodgkin Lymphoma Therapeutics Market, 2023 - 2030, USD Million
TABLE 53 Italy Non Hodgkin Lymphoma Therapeutics Market by Cell Type, 2019 - 2022, USD Million
TABLE 54 Italy Non Hodgkin Lymphoma Therapeutics Market by Cell Type, 2023 - 2030, USD Million
TABLE 55 Italy Non Hodgkin Lymphoma Therapeutics Market by Therapy Type, 2019 - 2022, USD Million
TABLE 56 Italy Non Hodgkin Lymphoma Therapeutics Market by Therapy Type, 2023 - 2030, USD Million
TABLE 57 Rest of Europe Non Hodgkin Lymphoma Therapeutics Market, 2019 - 2022, USD Million
TABLE 58 Rest of Europe Non Hodgkin Lymphoma Therapeutics Market, 2023 - 2030, USD Million
TABLE 59 Rest of Europe Non Hodgkin Lymphoma Therapeutics Market by Cell Type, 2019 - 2022, USD Million
TABLE 60 Rest of Europe Non Hodgkin Lymphoma Therapeutics Market by Cell Type, 2023 - 2030, USD Million
TABLE 61 Rest of Europe Non Hodgkin Lymphoma Therapeutics Market by Therapy Type, 2019 - 2022, USD Million
TABLE 62 Rest of Europe Non Hodgkin Lymphoma Therapeutics Market by Therapy Type, 2023 - 2030, USD Million
TABLE 63 Key Information – Pfizer, Inc.
TABLE 64 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 65 Key Information – Sanofi S.A.
TABLE 66 Key information – AbbVie, Inc.
TABLE 67 Key Information – Novartis AG
TABLE 68 Key Information – GlaxoSmithKline PLC
TABLE 69 Key Information – Johnson & Johnson
TABLE 70 Key Information – Takeda Pharmaceutical Company Limited
TABLE 71 Key Information – Bayer AG
TABLE 72 Key Information – Bristol-Myers Squibb Company
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Non Hodgkin Lymphoma Therapeutics Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Non Hodgkin Lymphoma Therapeutics Market
FIG 4 Porter’s Five Forces Analysis – Non Hodgkin Lymphoma Therapeutics Market
FIG 5 Europe Non Hodgkin Lymphoma Therapeutics Market share by Cell Type, 2022
FIG 6 Europe Non Hodgkin Lymphoma Therapeutics Market share by Cell Type, 2030
FIG 7 Europe Non Hodgkin Lymphoma Therapeutics Market by Cell Type, 2019 - 2030, USD Million
FIG 8 Europe Non Hodgkin Lymphoma Therapeutics Market share by Therapy Type, 2022
FIG 9 Europe Non Hodgkin Lymphoma Therapeutics Market share by Therapy Type, 2030
FIG 10 Europe Non Hodgkin Lymphoma Therapeutics Market by Therapy Type, 2019 - 2030, USD Million
FIG 11 Europe Non Hodgkin Lymphoma Therapeutics Market share by Country, 2022
FIG 12 Europe Non Hodgkin Lymphoma Therapeutics Market share by Country, 2030
FIG 13 Europe Non Hodgkin Lymphoma Therapeutics Market by Country, 2019 - 2030, USD Million
FIG 14 Recent strategies and developments: Pfizer Inc.
FIG 15 SWOT Analysis: Pfizer, Inc.
FIG 16 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 17 Swot Analysis: Sanofi S.A.
FIG 18 Swot Analysis: AbbVie, Inc.
FIG 19 SWOT Analysis: Novartis AG
FIG 20 SWOT Analysis: GlaxoSmithKline PLC
FIG 21 SWOT Analysis: Johnson & Johnson
FIG 22 SWOT Analysis:Takeda Pharmaceutical Company Limited
FIG 23 Swot Analysis: Bayer AG
FIG 24 SWOT Analysis: Bristol-Myers Squibb Company
Unique Offerings 
